1. Home
  2. ZLAB vs LPL Comparison

ZLAB vs LPL Comparison

Compare ZLAB & LPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • LPL
  • Stock Information
  • Founded
  • ZLAB 2013
  • LPL 1985
  • Country
  • ZLAB China
  • LPL South Korea
  • Employees
  • ZLAB N/A
  • LPL N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • LPL Industrial Machinery/Components
  • Sector
  • ZLAB Health Care
  • LPL Technology
  • Exchange
  • ZLAB Nasdaq
  • LPL Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • LPL 2.9B
  • IPO Year
  • ZLAB 2017
  • LPL 2004
  • Fundamental
  • Price
  • ZLAB $30.14
  • LPL $3.18
  • Analyst Decision
  • ZLAB Buy
  • LPL Sell
  • Analyst Count
  • ZLAB 4
  • LPL 2
  • Target Price
  • ZLAB $47.37
  • LPL N/A
  • AVG Volume (30 Days)
  • ZLAB 944.8K
  • LPL 195.4K
  • Earning Date
  • ZLAB 05-08-2025
  • LPL 05-15-2025
  • Dividend Yield
  • ZLAB N/A
  • LPL N/A
  • EPS Growth
  • ZLAB N/A
  • LPL N/A
  • EPS
  • ZLAB N/A
  • LPL N/A
  • Revenue
  • ZLAB $418,326,000.00
  • LPL $18,624,457,609.00
  • Revenue This Year
  • ZLAB $44.07
  • LPL N/A
  • Revenue Next Year
  • ZLAB $49.13
  • LPL N/A
  • P/E Ratio
  • ZLAB N/A
  • LPL N/A
  • Revenue Growth
  • ZLAB 43.72
  • LPL 23.70
  • 52 Week Low
  • ZLAB $16.01
  • LPL $2.43
  • 52 Week High
  • ZLAB $39.77
  • LPL $4.86
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 46.27
  • LPL 60.34
  • Support Level
  • ZLAB $30.11
  • LPL $2.97
  • Resistance Level
  • ZLAB $31.34
  • LPL $3.10
  • Average True Range (ATR)
  • ZLAB 1.09
  • LPL 0.07
  • MACD
  • ZLAB 0.07
  • LPL 0.00
  • Stochastic Oscillator
  • ZLAB 43.07
  • LPL 73.21

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LG Display Co Ltd is a South Korea-based company that is principally engaged in developing, manufacturing, and selling TFT-LCD and OLED display panels. The company's products consist of panels for notebook computers, monitors, televisions, smartphones, tablets, and others. The company conducts direct sales through overseas subsidiaries in several countries, including the United States, Germany, Japan, Taiwan, China, and Singapore. These subsidiaries conduct sales activities and offer technical support to clients. The company generates the majority of its revenue from overseas markets, with the rest from South Korea.

Share on Social Networks: